DOCSLIB.ORG

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six U.S

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six U.S ESID NT OF E PR EN E H M JU T T T S F O R T O F A I U.S. Department of Justice Executive Office of the President T C H P E P E LU M R U E E O IB N E U U S Y D C F U I F C I F I N C L F E I O B O T P O O F J E C L S N Office of Justice Programs Office of National Drug Control Policy E F A D V A O M V F O T R I I T S I N A O N T NA O T C I S R L C A E J J U D G G T B C R U E O O E S O JJ DP X F PR E JUSTICE National Institute of Justice National Institute Office of National of Justice Drug Control Policy R e s e a r& c h R e p o r t Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six U.S. Cities Executive Office of the President Office of National Drug Control Policy Washington, DC 20503 Barry R. McCaffrey Director U. S. Department of Justice Office of Justice Programs 810 Seventh Street N.W. Washington, DC 20531 Janet Reno Attorney General U.S. Department of Justice Raymond C. Fisher Associate Attorney General Laurie Robinson Assistant Attorney General Noël Brennan Deputy Assistant Attorney General Jeremy Travis Director, National Institute of Justice Department of Justice Response Center: 800–421–6770 Office of Justice Programs National Institute of Justice World Wide Web Site: World Wide Web Site: http://www.ojp.usdoj.gov http://www.ojp.usdoj.gov/nij Office of National Drug Control Policy World Wide Web Site: http://www.whitehousedrugpolicy.gov Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six U.S. Cities K. Jack Riley A report on research conducted under the joint auspices of the National Institute of Justice and the Office of National Drug Control Policy December 1997 Office of National Drug Control Policy Barry R. McCaffrey Director National Institute of Justice Jeremy Travis Director K. Jack Riley, Ph.D., is director of the Arrestee Drug Abuse Monitoring program at the National Institute of Justice. Opinions or points of view expressed in this document do not necessarily reflect the official position of the U.S. Department of Justice or the Office of National Drug Control Policy. The National Institute of Justice is a component of the Office of Justice Programs, which also includes the Bureau of Justice Assistance, the Bureau of Justice Statistics, the Office of Juvenile Justice and Delinquency Prevention, and the Office for the Victims of Crime. NCJ 167265 iii Contents Acknowledgments ....................................................................................................................... vii Executive Summary.................................................................................................................... 1 Summary of User Findings Summary of Purchase Patterns Summary of Use Patterns Study Methodology ..................................................................................................................... 3 Profile of Users ............................................................................................................................ 6 Age Living Arrangements Sources of Income Arrest Charges Race and Drug Use Purchase Patterns ....................................................................................................................... 14 Buyer-Seller Relations Dealer Networks Location of Purchases Failed Transactions Purchase Frequency Guns and Drug Purchases Use Patterns................................................................................................................................. 21 Three-Day Use Daily Use Duration of Use Cessation of Use Conclusions and Implications .................................................................................................... 24 Drug User Profile Drug Purchase Patterns Drug Use Patterns Policy Implications Notes............................................................................................................................................. 26 Appendix ..................................................................................................................................... 29 v List of Tables Table 1. Attrition of Participants in Main DUF........................................................................ 4 Table 2. Eligibility for Participation in Procurement Study, by Drug, Gender, and Age Group............................................................................................................ 4 Table 3. Percentage of Eligible Arrestees Participating in Procurement Study, by Gender and Age Group............................................................................................................ 5 Table 4. Number of Individuals Participating in Procurement Study, by Interview Type ....... 5 Table 5. Participants in Procurement Study, by Gender and Age Group ................................. 6 Table 6. Participants in Procurement Study, by Race .............................................................. 6 Table 7. Mean Age of Participants in Procurement Study, by Drug ........................................ 7 Table 8. Living Arrangements Prior to Arrest, as Percentage of Total Participants, by Site and Drug ......................................................................................................... 8 Table 9. Main Sources of Income Prior to Arrest, by Site and Drug ....................................... 9 Table 10. Average Monthly Income in Manhattan, by Reported Primary Source of Income.... 10 Table 11. Arrest Charges of Study Participants.......................................................................... 11 Table 12. Drug Use by Race of Arrestees .................................................................................. 12 Table 13. Race of Arrestees by Category of Drug Use .............................................................. 13 Table 14. Percentage of Respondents Using a Main Source, by Drug ....................................... 14 Table 15. Percentage of Respondents Using a Main Source, by Race and Drug ....................... 14 Table 16. Contingency Table of Use of Main Source Among Crack Users, by Race................ 15 Table 17. Number of Dealers Known, by Drug Used ................................................................ 16 Table 18. Percentage of Respondents Typically Making Purchases Outdoors .......................... 17 Table 19. Percentage of Respondents Typically Making Purchases In Their Own Neighborhoods ..................................................................................... 17 Table 20. Percentage of Respondents with Failed Purchase Transactions in the Past Year ...... 18 Table 21. Reasons Cited for Failed Transactions ....................................................................... 19 Table 22. Percentage Reporting a Drug Purchase in the Week Prior to Arrest .......................... 20 Table 23. Mean Number of Purchases Made in the Week Prior to Arrest ................................. 20 Table 24. Drug Test Results by Completed Addendum Interview............................................. 21 Table 25. Drug Test Results for General DUF Population......................................................... 22 vi Table 26. Percentage Describing Themselves as Daily Users, by Drug Used ........................... 22 Table 27. Mean Number of Daily Uses Among Those Describing Themselves as Daily Users ............................................................................................................. 23 Table 28. Mean Number of Past Week Uses Among Those Describing Themselves as Not Daily Users ....................................................................................................... 23 Table 29. Percentage of Respondents Reporting 30 or More Consecutive Days of Use In the 90 Days Prior to Arrest..................................................................................... 23 Table 30. Percentage of Respondents Reporting 30 or More Consecutive Days Of Abstinence in the 90 Days Prior to Arrest............................................................. 24 Table 31. Motivations for Periods of Abstinence Among Manhattan Arrestees, by Drug ........ 24 vii Acknowledgments The National Institute of Justice (NIJ) and thoughtful suggestions for the project and the Office of National Drug Control Policy helpful reviews of draft reports. In addi- (ONDCP) would like to acknowledge the tion, two anonymous reviewers provided contributions of individuals and organiza- valuable critiques of an early draft. Many tions whose efforts made this project pos- DUF site staff contributed to making this sible. ONDCP provided the resources to project happen by collecting the data, and fund the project. NIJ provided staff re- their cooperation is greatly appreciated: sources and access to the Drug Use Fore- James Swartz, Scott Slomka, and Norm casting (DUF) sites that participated in the Hamilton (Chicago); Bruce D. Johnson, project. Staff of BOTEC Analysis Corpora- Tom Miller, Phyllis Curry, Elliott Quino- tion—including Ann Marie Rocheleau, nes, and Diane Concepcion (Manhattan); Jennifer Jackson, and Andrew Lockwood Diane Wiscarson (Portland, Oregon); Ed Chalsma—were key to designing the inter- Baca and James Daniels (San Antonio); view instrument, conducting training, and Susan Pennell and Ami Caldwell (San Di- preparing the data. Similarly, Rosalee ego); and LaVon Williams (Washington, Copeland and Jeremy Yuan at Aspen Sys- D.C.). Special thanks go out to Bruce D. tems Corporation’s Applied Management Johnson, Susan Pennell, and Ami Caldwell Sciences Group provided data runs and for their work on developing
Load more

Recommended publications
  • Medications to Treat Opioid Use Disorder Research Report
    Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States.
    [Show full text]
  • National Vital Statistics Report: Drugs Most Frequently Involved In
    National Vital Statistics Reports Volume 67, Number 9 December 12, 2018 Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016 by Holly Hedegaard, M.D., M.S.P.H., and Brigham A. Bastian, B.S., National Center for Health Statistics; James P. Trinidad, M.P.H., M.S., U.S. Food and Drug Administration; Merianne Spencer, M.P.H., and Margaret Warner, Ph.D., National Center for Health Statistics Abstract overdose deaths involving methadone decreased from 1.4 per 100,000 in 2011 to 1.1 in 2016. The 10 most frequently Objective—This report identifies the specific drugs involved mentioned drugs often were found in combination with each most frequently in drug overdose deaths in the United States other. The drugs most frequently mentioned varied by the intent from 2011 through 2016. of the drug overdose death. In 2016, the drugs most frequently Methods—Record-level data from the 2011–2016 National mentioned in unintentional drug overdose deaths were fentanyl, Vital Statistics System–Mortality files were linked to electronic heroin, and cocaine, while the drugs most frequently mentioned files containing literal text information from death certificates. in suicides by drug overdose were oxycodone, diphenhydramine, Drug overdose deaths were identified using the International hydrocodone, and alprazolam. Classification of Diseases, Tenth Revision underlying cause- Conclusions—This report identifies patterns in the specific of-death codes X40–X44, X60–X64, X85, and Y10–Y14. Drug drugs most frequently involved in drug overdose deaths from mentions were identified by searching the literal text in three 2011 through 2016 and highlights the importance of complete fields of the death certificate: the causes of death from Part I, and accurate reporting in the literal text on death certificates.
    [Show full text]
  • What Are the Treatments for Heroin Addiction?
    How is heroin linked to prescription drug abuse? See page 3. from the director: Research Report Series Heroin is a highly addictive opioid drug, and its use has repercussions that extend far beyond the individual user. The medical and social consequences of drug use—such as hepatitis, HIV/AIDS, fetal effects, crime, violence, and disruptions in family, workplace, and educational environments—have a devastating impact on society and cost billions of dollars each year. Although heroin use in the general population is rather low, the numbers of people starting to use heroin have been steadily rising since 2007.1 This may be due in part to a shift from abuse of prescription pain relievers to heroin as a readily available, cheaper alternative2-5 and the misperception that highly pure heroin is safer than less pure forms because it does not need to be injected. Like many other chronic diseases, addiction can be treated. Medications HEROIN are available to treat heroin addiction while reducing drug cravings and withdrawal symptoms, improving the odds of achieving abstinence. There are now a variety of medications that can be tailored to a person’s recovery needs while taking into account co-occurring What is heroin and health conditions. Medication combined with behavioral therapy is particularly how is it used? effective, offering hope to individuals who suffer from addiction and for those around them. eroin is an illegal, highly addictive drug processed from morphine, a naturally occurring substance extracted from the seed pod of certain varieties The National Institute on Drug Abuse (NIDA) has developed this publication to Hof poppy plants.
    [Show full text]
  • Adolescent Drug Terminology and Trends: 2017-18 Edition
    Adolescent Drug Terminology and Trends: 2017-18 Edition Matthew Quinn, LCPC, CADC Community Relations Coordinator Vaping Term used to describe when a substance is heated to the point of releasing vapor but not combusted (lit on fire). • Increasing in popularity as a way to ingest nicotine and cannabis, often in an electronic device that looks like a pen • Usually relatively odorless and difficult to distinguish between nicotine and cannabis vape device Juul (pronounced jewel) Specific vaping product from Pax Labs similar to an e- cigarette used to ingest nicotine • Liquid contains nicotine salts extracted from the tobacco leaf (2x nicotine of previous e-cigs) • Variety of flavors • Cool mint • Mango • Crème brule Dabs Dabs is a highly concentrated butane hash oil (BHO) created in a process where high quality cannabis is blasted with butane and extracted. • Heated and inhaled • Contains 70-90% THC compared to 5-15% THC in regular cannabis • Wax, oil, shatter, crumble • Sauce, distillate Rig A rig is a device used to vaporize and inhale dabs. • Looks similar to a water pipe or bong • Usually a nail is heated with a hand- held torch to a high temperature and a small piece of the concentrate is ‘dabbed’ onto a nail • Vapor released is then inhaled through the pipe Edibles • Increasingly popular alternative to smoking marijuana • Produced to infuse marijuana into various ingestible forms • Problem is that effects are hard to predict and difficult to know dose Other Terms for Cannabis • Bud • Dank • Nug • Loud • Fire • Gas Bars (Ladders) Another name for the rectangular shaped Xanax (anti- anxiety medication) with three lines in them (typically 2mg per ‘bar’).
    [Show full text]
  • Drug Fact Sheet: Oxycodone
    Oxycodone WHAT IS OXYCODONE? What is its effect on the mind? Oxycodone is a semi-synthetic narcotic analgesic Euphoria and feelings of relaxation are the most and historically has been a popular drug of abuse common effects of oxycodone on the brain, which among the narcotic abusing population. explains its high potential for abuse. WHAT IS ITS ORIGIN? What is its effect on the body? Oxycodone is synthesized from thebaine, a Physiological effects of oxycodone include: constituent of the poppy plant. • Pain relief, sedation, respiratory depression, constipation, papillary constriction, and cough What are common street names? suppression. Extended or chronic use of oxycodone Common street names include: containing acetaminophen may cause severe liver • Hillbilly Heroin, Kicker, OC, Ox, Roxy, Perc, and Oxy damage What does it look like? What are its overdose effects? Oxycodone is marketed alone as OxyContin® in Overdose effects include: 10, 20, 40 and 80 mg extended-release tablets • Extreme drowsiness, muscle weakness, confusion, cold and other immediate-release capsules like 5 and clammy skin, pinpoint pupils, shallow breathing, mg OxyIR®. It is also marketed in combination slow heart rate, fainting, coma, and possible death products with aspirin such as Percodan® or acetaminophen such as Roxicet®. Which drugs cause similar effects? Drugs that cause similar effects to Oxycodone How is it abused? include: Oxycodone is abused orally or intravenously. • Opium, codeine, heroin, methadone, hydrocodone, The tablets are crushed and sniffed or dissolved fentanyl, and morphine in water and injected. Others heat a tablet that has been placed on a piece of foil then inhale the What is its legal status in the United States? vapors.
    [Show full text]
  • NIDA Modified ASSIST (Pdf)
    1 NIDA Quick Screen V1.0F Name: ......................................................................... Sex ( ) F ( ) M Age....... Interviewer........................................ Date ....../....../...... Introduction (Please read to patient) Hi, I’m __________, nice to meet you. If it’s okay with you, I’d like to ask you a few questions that will help me give you better medical care. The questions relate to your experience with alcohol, cigarettes, and other drugs. Some of the substances we’ll talk about are prescribed by a doctor (like pain medications). But I will only record those if you have taken them for reasons or in doses other than prescribed. I’ll also ask you about illicit or illegal drug use––but only to better diagnose and treat you. Instructions: For each substance, mark in the appropriate column. For example, if the patient has used cocaine monthly in the past year, put a mark in the “Monthly” column in the “illegal drug” row. NIDA Quick Screen Question: In the past year, how often have you used the following? Daily Twice Never Almost Almost Weekly Daily or Once or Monthly Alcohol • For men, 5 or more drinks a day • For women, 4 or more drinks a day Tobacco Products Prescription Drugs for Non-Medical Reasons Illegal Drugs . If the patient says “NO” for all drugs in the Quick Screen, reinforce abstinence. Screening is complete. If the patient says “Yes” to one or more days of heavy drinking, patient is an at-risk drinker. Please see NIAAA website “How to Help Patients Who Drink Too Much: A Clinical Approach” http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/clinicians_guide.htm, for information to Assess, Advise, Assist, and Arrange help for at risk drinkers or patients with alcohol use disorders .
    [Show full text]
  • What Is Cocaine?
    WHAT IS COCAINE? AN EDUCATIONAL FACT SHEET FROM THE FLORIDA ALCOHOL & DRUG ABUSE ASSOCIATION Cocaine is a powerful central nervous sys- OTHER WAYS OF USING COCAINE tem stimulant that comes from the South Ameri- The most dangerous form of smokable cocaine can coca bush. The cocaine (cocaine hydrochlo- is coca paste made by using gasoline or sulfuric acid ride) most commonly used in the U.S. is a white to extract a smokable paste. The paste is dried and crystalline powder extracted from coca leaves. smoked in a pipe or crushed into a cigarette. The cocaine bought on the street is a mixture of pure cocaine and other substances such as talc, Cocaine may be used with other drugs to pro- flour, laxatives, sugar, local anesthetics and other duce a variety of effects. “Speedballing” is the com- stimulants or powders that are added to stretch bination of cocaine and heroin in a syringe for in- the supply and increase the seller’s profit. jection. “Spaceballing” is the sprinkling of liquid Users buy powdered cocaine in grams (1/ PCP (Phencyclidine) on crack cocaine before smok- 28 of an ounce) or in fractions of a gram called ing. “Champagne” is the combination of cocaine and “quarters” or “eighths.” Often, cocaine is snorted marijuana. through the nose. Razor blades are used to crush any large rocks or particles of cocaine and to form “lines” that make snorting easier. Some SHORT-TERM EFFECTS users inject cocaine into a muscle or vein; others When cocaine is snorted, the effects begin convert it into a smokable form called freebase.
    [Show full text]
  • Hallucinogens
    Hallucinogens What are hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their own thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and some are synthetic (human- made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes, including to have fun, deal with stress, have spiritual experiences, or just to feel different. Common classic hallucinogens include the following: • LSD (D-lysergic acid diethylamide) is one of the most powerful mind-altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other grains. LSD has many other street names, including acid, blotter acid, dots, and mellow yellow. • Psilocybin (4-phosphoryloxy-N,N- dimethyltryptamine) comes from certain types of mushrooms found in tropical and subtropical regions of South America, Mexico, and the United States. Some common names for Blotter sheet of LSD-soaked paper squares that users psilocybin include little smoke, magic put in their mouths. mushrooms, and shrooms. Photo by © DEA • Peyote (mescaline) is a small, spineless cactus with mescaline as its main ingredient. Peyote can also be synthetic.
    [Show full text]
  • Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019
    OSAMOSAM OhioOhio Substance Substance Abuse Abuse Monitoring Monitoring Network Network SurveillanceSurveillance of of Drug Drug Abuse Abuse Trends Trends in the State of Ohio January - June 2019 Lake Ashtabula Fulton Lucas Williams Ottawa Geauga Cuyahoga Defiance Henry Wood Sandusky Erie Lorain Trumbull Huron Summit Portage Paulding Seneca Medina Putnam Hancock Mahoning Van Wert Wyandot Crawford Ashland Wayne Stark Columbiana Allen Richland Hardin Marion Mercer Auglaize Holmes Carroll Morrow Tuscarawas Jefferson Logan Knox Shelby Union Delaware Coshocton Harrison Champaign Darke Licking Miami Guernsey Belmont Franklin Muskingum Clark Madison Montgomery Preble Fairfield Perry Noble Monroe Greene Pickaway Fayette Morgan Hocking Washington Butler Warren Clinton Ross Athens Vinton Hamilton Highland Clermont Pike Meigs Jackson Brown Adams Scioto Gallia Lawrence Legend Akron-Canton region Columbus region Athens region Dayton region Cincinnati region Toledo region Cleveland region Youngstown region Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019 Prepared by: Ohio Department of Mental Health and Addiction Services Office of Quality, Planning and Research R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Sarah Balser, OSAM Coordinator — MPH, MSW, LSW, CHES Jessica Linley, OSAM Quantitative Data Analyst — PhD, MSW, LSW Table of Contents OSAM-O-Gram....................................................................................................................................................................3
    [Show full text]
  • Dangerous New Street Drug Cocktail
    Ashly Custer City of Rio Grande City Public Relations Cell: (956)257-1027 Email: [email protected] PUBLIC NOTICE/WARNING: DANGEROUS NEW STREET DRUG COCKTAIL The Rio Grande City Police Department has received information that street level drug dealers are mixing crack cocaine with methamphetamine and passing it off as regular crack cocaine. This is a deadly mix for any user since most of the time have no idea what they are smoking. We encourage our community to get involved in the fight against drugs and report any location they believe is selling narcotics. METHAMPHETAMINE Meth, or methamphetamine, is an intense and highly addictive stimulant that is commonly snorted, smoked, or injected directly into one’s veins. Those taking meth typically want a fast or even instant high, the effects peak in 1-15 minutes and generally last 4-8 hours. Unfortunately, ingesting any kind of drugs via these methods is both dangerous and damaging to one’s health. Considering how devastating meth is in any form, these risks are very serious for meth users and have resulted in many deaths. According to new research from Toronto's Centre for Addiction and Mental Health (CAMH), researchers found that people who regularly abuse meth are an average of 4.67 times more likely to die than those who do not use drugs. CRACK COCAINE In addition to the usual risks associated with cocaine use, crack users may experience severe respiratory problems, including coughing, shortness of breath, lung damage and bleeding. Long-term effects from use of crack cocaine include severe damage to the heart, liver and kidneys.
    [Show full text]
  • Commonly Used Drugs
    Commonly Used Drugs Many drugs can alter a person’s thinking and judgment, and can lead to health risks, including addiction, drugged driving, infectious disease, and adverse effects on pregnancy. Information on commonly used drugs with the potential for misuse or addiction can be found here. For information about treatment options for substance use disorders, see NIDA’s Treatment pages. For drug use trends, see our Trends and Statistics page. For the most up-to-date slang terms, please see Slang Terms and Code Words: A Reference for Law Enforcement Personnel (DEA, PDF, 1MB). The following drugs are included in this resource: ➢ Alcohol ➢ Methamphetamine ➢ Ayahuasca ➢ Over-the-Counter Medicines--Dextromethorphan ➢ Central Nervous System Depressants (DXM) ➢ Cocaine ➢ Over-the-Counter Medicines--Loperamide ➢ DMT ➢ PCP ➢ GHB ➢ Prescription Opioids ➢ Hallucinogens ➢ Prescription Stimulants ➢ Heroin ➢ Psilocybin ➢ Inhalants ➢ Rohypnol® (Flunitrazepam) ➢ Ketamine ➢ Salvia ➢ Khat ➢ Steroids (Anabolic) ➢ Kratom ➢ Synthetic Cannabinoids ➢ LSD ➢ Synthetic Cathinones ("Bath Salts") ➢ Marijuana (Cannabis) ➢ Tobacco/Nicotine ➢ MDMA (Ecstasy/Molly) ➢ Mescaline (Peyote) **Drugs are classified into five distinct categories or schedules “depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.” More information and the most up-to-date scheduling information can be found on the Drug Enforcement Administration’s website. June 2020 Alcohol People drink to socialize, celebrate, and relax. Alcohol often has a strong effect on people—and throughout history, people have struggled to understand and manage alcohol’s power. Why does alcohol cause people to act and feel differently? How much is too much? Why do some people become addicted while others do not? The National Institute on Alcohol Abuse and Alcoholism is researching the answers to these and many other questions about alcohol.
    [Show full text]
  • Phencyclidine: an Update
    Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]